GALT Deficiency Galactosemia.

Area of Science:

• Biochemistry
• Genetics
• Pediatrics

Background:

• Galactosemia is an inherited metabolic disorder characterized by the inability to properly metabolize galactose.
• It arises from deficiencies in specific enzymes involved in galactose metabolism, most commonly galactose-1-phosphate uridyltransferase (GALT).
• Newborn screening programs are crucial for early detection of galactosemia.

Purpose of the Study:

• To provide a comprehensive overview of galactosemia, with a specific focus on GALT enzyme deficiency.
• To detail the different subtypes: classical, clinical variant, and biochemical variant (Duarte) galactosemias.
• To discuss diagnostic and management strategies, including genetic counseling.

Main Methods:

• Review of existing literature on galactosemia and GALT enzyme deficiency.
• Synthesis of information regarding newborn screening, confirmatory testing, and management protocols.
• Emphasis on the role of genetic counseling and testing in affected families.

Main Results:

• Galactosemia presents with varied clinical manifestations depending on the specific enzyme deficiency and subtype.
• Early diagnosis through newborn screening and prompt management significantly improve patient outcomes.
• Genetic testing is essential for accurate diagnosis, understanding inheritance patterns, and reproductive risk assessment.

Conclusions:

• GALT enzyme deficiency accounts for the most common and severe forms of galactosemia.
• A multidisciplinary approach involving timely diagnosis, appropriate medical management, and genetic counseling is vital for managing galactosemia.
• Understanding the nuances of different galactosemia subtypes ensures tailored care and informed reproductive planning for families.